Pooled analysis of phase 2 reports of 2 v 1 course of carboplatin as adjuvant for stage 1 seminoma.

被引：0
|
作者：
Oliver, T
Dieckmann, KP
Steiner, H
Skoneczna, I
机构：
[1] QMUL, St Barts & London Sch Med, London, England
[2] Albertenan Hosp, Hamburg, Germany
[3] Med Univ Innsbruck, Innsbruck, Austria
[4] Inst Oncol, Warsaw, Poland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：395S / 395S
页数：1
相关论文
共 50 条
  • [1] Anglian germ cell cancer group randomised phase 2 toxicity comparison of one course carboplatin verses radiotherapy for stage 1 seminoma.
    Harper, P
    MacDonald, L
    Tong, D
    Robinson, A
    Lamont, A
    Trask, C
    Jackson, W
    Levay, J
    Mantell, BS
    Oliver, RTD
    Ong, J
    Xu, L
    BRITISH JOURNAL OF CANCER, 1996, 74 : PO15 - PO15
  • [2] Real-world Outcomes of Adjuvant Carboplatin in Stage 1 Seminoma
    Ding, T. G.
    Christides, A.
    Malik, J.
    Law, A.
    CLINICAL ONCOLOGY, 2022, 34 (03) : E144 - E144
  • [3] The long term side effects of adjuvant carboplatin for stage 1 seminoma
    Powles, T.
    Oliver, T.
    Ostrowski, M.
    Levay, J.
    Shamash, J.
    Williams, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] The challenge to one-course carboplatin in seminoma clinical stage 1
    Dieckmann, K. -P.
    Anheuser, P.
    ANNALS OF ONCOLOGY, 2016, 27 (08) : 1648 - 1649
  • [5] PILOT-STUDIES OF 2-COURSE AND 1-COURSE CARBOPLATIN AS ADJUVANT FOR STAGE-I SEMINOMA - SHOULD IT BE TESTED IN A RANDOMIZED TRIAL AGAINST RADIOTHERAPY
    OLIVER, RTD
    EDMONDS, PM
    ONG, JYH
    OSTROWSKI, MJ
    JACKSON, AW
    BAILLEJOHNSON, H
    WILLIAMS, MV
    WILTSHIRE, CR
    MOTT, T
    PRATT, WR
    TRASK, CWL
    HOPESTONE, HF
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (01): : 3 - 8
  • [6] Reply to 'The challenge to one course carboplatin in seminoma clinical stage 1' by Dieckmann and Anheuser
    Tandstad, T.
    Cohn-Cedermark, G.
    ANNALS OF ONCOLOGY, 2016, 27 (09) : 1809 - 1809
  • [7] Adjuvant carboplatin therapy in patients with clinical stage 1 testicular seminoma: is long-term morbidity increased?
    Christian Guido Ruf
    Stefan Borck
    Petra Anheuser
    Cord Matthies
    Tim Nestler
    Henrik Zecha
    Hendrik Isbarn
    Klaus-Peter Dieckmann
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 2335 - 2342
  • [8] Adjuvant carboplatin therapy in patients with clinical stage 1 testicular seminoma: is long-term morbidity increased?
    Ruf, Christian Guido
    Borck, Stefan
    Anheuser, Petra
    Matthies, Cord
    Nestler, Tim
    Zecha, Henrik
    Isbarn, Hendrik
    Dieckmann, Klaus-Peter
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (09) : 2335 - 2342
  • [9] Re: Adjuvant Carboplatin Therapy in Patients with Clinical Stage 1 Testicular Seminoma: Is Long-Term Morbidity Increased?
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2019, 202 (06): : 1099 - 1099
  • [10] Adjuvant Carboplatin for Clinical Stage 1 Testicular Seminoma in New Zealand Centres: Retrospective Analysis of Efficacy and Long-Term Adverse Effects
    Chandran, Elias
    Chindewere, Aaron
    North, Richard
    Jameson, Michael
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 44 - 45
12345